Priority Date: 20.12.11 (FR 20110062071)

METHOD FOR THE DIAGNOSIS OR PROGNOSIS, IN VITRO, OF TESTICULAR CANCER

  • Application ID: EP12816751
  • Status: █ The patent has been granted

Applicant

Technology company logo small
Biomérieux Inc.
Technology Company

Attorney

Missing person image small
Stéphane Agasse
operating since 1849
1267.25
Cabinet Germain & Maureau
Headquarter in Lyon and 6 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Cabinet Germain & Maureau is specialised in C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 20.12.2011 - Priority Date (FR 20110062071)
  • 27.06.2013 - Publication A2 (WO2013093356)
  • 29.10.2014 - Publication A2 (EP2794922)
  • 25.04.2018 - Publication B1 (EP2794922)

IPC Classification